Support LinksChrome Firefox Safari Edge View Versions © 2025 Advarra, Inc.

To search for a clinical trial (protocol), use any or all of the search fields: Select from drop down lists or type search criteria in any of the text fields. Browse by Physician or Drug, use the …

Inclusion Criteria Pre-Registration Eligibility Criteria: Patients must have pathologically confirmed pancreatic adenocarcinoma.Received 4-6 months of induction chemotherapy with either …

Inclusion Criteria Inclusion Criteria Male or female subject aged >= 18 years.Histologically confirmed urothelial carcinoma with metastatic disease or with unresectable, locally advanced …

SIP Version 14.0.0.010 Copyright © 2001-2020 Forte Research Systems, Inc. all rights reserved.

Objectives Primary Objective To compare overall survival in participants with newly diagnosed metastatic renal cell carcinoma who are randomized to receive immune checkpoint inhibitor …

Inclusion Criteria Male or female subject aged >= 18 years.Histologically confirmed diagnosis of CLL per iwCLL criteria. History of >=1 non-melanoma skin cancer (NMSC) diagnosed within …

Objectives Primary Objective To assess the safety and tolerability of using hypoxia PET/CT imaging with Fluorine-18 fluoromisonidazole (FMISO) and MRI measures of radioresistance to …

All men seen at this Prostate Cancer Risk Clinic (as well as all HCI cancer patients, family members, and healthy volunteers) are invited to enroll in IRB #89989, Total Cancer Care. IRB …

Objectives The objectives of this study is to evaluate the efficacy and safety of IMMU-132 in previously treated metastatic urothelial cancers.